Evidence map›Paper›PMID 32413033›Full record

ArticlePloS one2020

Indoor and outdoor residual spraying of a novel formulation of deltamethrin K-Othrine® (Polyzone) for the control of simian malaria in Sabah, Malaysia.

A Rohani, H Ahmad Fakhriy, I Suzilah, M N Zurainee, W M A Wan Najdah, M Mohd Ariffin, N Mohamad Shakirudin, M S Mohd Afiq, J Jenarun, Y Tanrang and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. PredictingFrontiers in microbiology · 2023
    Article
  10. Review
  11. Narrative Review of the Control and Prevention of Knowlesi Malaria.Tropical medicine and infectious disease · 2022
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

A RohaniMedical Entomology Unit & WHO Collaborating Centre for Vectors, Institute for Medical Research, Kuala Lumpur, Malaysia.
H Ahmad FakhriyMedical Entomology Unit & WHO Collaborating Centre for Vectors, Institute for Medical Research, Kuala Lumpur, Malaysia.ORCID 0000-0001-5211-8914
I SuzilahSchool of Quantitative Sciences, Universiti Utara Malaysia, Sintok Kedah, Malaysia.
M N ZuraineeParasitology Department, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia.
W M A Wan NajdahMedical Entomology Unit & WHO Collaborating Centre for Vectors, Institute for Medical Research, Kuala Lumpur, Malaysia.
M Mohd AriffinMedical Entomology Unit & WHO Collaborating Centre for Vectors, Institute for Medical Research, Kuala Lumpur, Malaysia.
N Mohamad ShakirudinMedical Entomology Unit & WHO Collaborating Centre for Vectors, Institute for Medical Research, Kuala Lumpur, Malaysia.
M S Mohd AfiqMedical Entomology Unit & WHO Collaborating Centre for Vectors, Institute for Medical Research, Kuala Lumpur, Malaysia.
J JenarunSabah Department of Health, Kementerian Kesihatan Malaysia, Kota Kinabalu, Sabah, Malaysia.
Y TanrangSabah Department of Health, Kementerian Kesihatan Malaysia, Kota Kinabalu, Sabah, Malaysia.
H L LeeMedical Entomology Unit & WHO Collaborating Centre for Vectors, Institute for Medical Research, Kuala Lumpur, Malaysia.
Institute for Medical Research · MYMinistry of Health · MYUniversity of Malaya · MYNorthern University of Malaysia · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since 2000, human malaria cases in Malaysia were rapidly reduced with the use of insecticides in Indoor Residual Spray (IRS) and Long-Lasting Insecticide Net (LLIN). Unfortunately, monkey malaria in humans has shown an increase especially in Sabah and Sarawak. The insecticide currently used in IRS is deltamethrin K-Othrine® WG 250 wettable granule, targeting mosquitoes that rest and feed indoor. In Sabah, the primary vector for knowlesi malaria is An. balabacensis a species known to bite outdoor. This study evaluates an alternative method, the Outdoor Residual Spray (ORS) using a novel formulation of deltamethrin K-Othrine® (PolyZone) to examine it suitability to control knowlesi malaria vector in Sabah, compared to the current method. The study was performed at seven villages in Sabah having similar type of houses (wood, bamboo and concrete). Houses were sprayed with deltamethrin K-Othrine® (PolyZone) at two different dosages, 25 mg/m2 and 30 mg/m2 and deltamethrin K-Othrine® WG 250 wettable granule at 25 mg/m2, sprayed indoor and outdoor. Residual activity on different walls was assessed using standard cone bioassay techniques. For larval surveillances, potential breeding sites were surveyed. Larvae were collected and identified, pre and post spraying. Adult survey was done using Human Landing Catch (HLC) performed outdoor and indoor. Detection of malaria parasite in adults was conducted via microscopy and molecular methods. Deltamethrin K-Othrine® (PolyZone) showed higher efficacy when sprayed outdoor. The efficacy was found varied when sprayed on different types of wall surfaces. Deltamethrin K-Othrine® (PolyZone) at 25 mg/m2 was the most effective with regards to ability to high mortality and effective knock down (KD). The vector population was reduced significantly post-spraying and reduction in breeding sites as well. The number of simian malaria infected vector, human and simian malaria transmission were also greatly reduced.

Indexed as

AerosolsAnimalsAnophelesHaplorhiniInsecticidesMalariaMalaysiaNitrilesParasitic Diseases, AnimalPlasmodium knowlesiPyrethrinsAerosolsdecamethrinInsecticidesNitrilesPyrethrins

Identifiers

PMID32413033
PMCPMC7228059
OpenAlexW3025344511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.